Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adnexus Therapeutics Inc.

Division of Bristol-Myers Squibb Co.
www.adnexustx.com

Latest From Adnexus Therapeutics Inc.

Editas Seeks New CEO, CFO Ahead of CRISPR Specialist's New Clinical Era

Katrine Bosley’s announced departure as Editas' CEO follows news its CFO Andrew Hack is leaving to join Bain Capital - and just as the gene-editing specialist prepares to administer its ground-breaking CRISPR medicine to humans in the clinic.

Leadership Business Strategies

Deal Watch: Novartis Signs Deals In Migraine & Diabetes

Novartis will invest in the Calgary-based Parvus and collaborate on a Navacim candidate for type 1 diabetes. Japan's Sawai moves into the US market by acquiring Upsher-Smith's generics business, while Denovo acquires a suspended depression candidate from AMRI for its personalized development approach.

Deals M & A

Venture Creation Story: The Early Days Of Moderna

From pioneering stem-cell work to trade secrets a la Coca-Cola, what it means when a company – in this case, the RNA therapeutics developer Moderna – comes through Flagship Ventures’ VentureLabs group.

BioPharmaceutical United States

People In Brief

Reddy’s CEO adds chairman title; NattoPharma names Anderson sales and marketing SVP; Cuss takes on CSO post at Bristol-Myers Squibb; Rodgers and Hall swap House subcommittee seats; Life Extension hires product development leader; more People In Brief.

Consumer United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Compound Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bristol-Myers Squibb Co.
  • Senior Management
  • John Mendlein, PhD, CEO
    John Edwards, COO
  • Contact Info
  • Adnexus Therapeutics Inc.
    Phone: (781) 891-3745
    100 Beaver St.
    Waltham, MA 02453
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register